ArticleHepatology forum2024
Risk factors for relapse after discontinuation of tenofovir or entecavir in hepatitis B e antigen-negative patients.
Cigdem Mermutluoglu et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it